rTMS of the prefrontal cortex has analgesic effects on neuropathic pain in subjects with spinal cord injury.
R Nardone, Y Höller, P B Langthaler...
https://pubmed.ncbi.nlm.nih.gov/27241450Actively Recruiting
Led by Afyonkarahisar Health Sciences University · Updated on 2026-03-09
60
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying the effect of high-frequency repetitive transcranial magnetic stimulation (rTMS) applied to the dorsolateral prefrontal cortex (DLPFC) on neuropathic pain in patients with spinal cord injury (SCI). Neuropathic pain is a common and challenging complication after SCI, and this study aims to explore how rTMS, a non-invasive brain stimulation technique, may help relieve this pain by targeting the DLPFC area. The study addresses a gap in research by focusing on this specific brain region and its impact on neuropathic pain. Participants will be randomly assigned to one of two groups. One group will receive daily high-frequency rTMS at 10 Hz with 1200 pulses applied to the dorsolateral prefrontal cortex for 15 sessions, at 110% intensity of the motor threshold. The other group will receive daily sham rTMS sessions with the same schedule. Throughout the treatment period, participants will continue their current medication for neuropathic pain without dose changes. During the study, participants will be assessed at the start, after 15 days, and at 6 weeks. Researchers will measure changes in pain using the Visual Analog Scale (VAS) and other pain and quality of life questionnaires, including the Leeds Assessment of Neuropathic Symptoms & Signs (LANSS), the Short Form McGill Pain questionnaire (SF-MPQ), and the Short Form 36 (SF-36). Depression and anxiety levels will also be monitored using the Beck Depression and Anxiety Scales. The study monitors safety and the impact of rTMS on neuropathic pain over this period.
CONDITIONS
Transcranial Magnetic Stimulation Therapy in Neuropathic Painful Spinal Cord Injury Patients
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 15 days
Participants receive daily transcranial magnetic stimulation to the dorsolateral prefrontal cortex for 15 sessions while continuing their current medication regimen without dose changes.
Daily visits for 15 days (in-person)
Duration - Up to 6 weeks
Participants are monitored for changes in neuropathic pain and other health outcomes up to 6 weeks after treatment.
1 visit at 15 days and 1 visit at 6 weeks (in-person)
Total: 1 location
1
Afyonkarahisar
Afyonkarahisar, Turkey (Türkiye), 0300
Actively Recruiting
N
Nuran EYVAZ, MD
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
R Nardone, Y Höller, P B Langthaler...
https://pubmed.ncbi.nlm.nih.gov/27241450Qi-Hao Yang, Yong-Hui Zhang, Shu-Hao Du...
https://pubmed.ncbi.nlm.nih.gov/35663263Lingling Li, Hailiang Huang, Ying Yu...
https://pubmed.ncbi.nlm.nih.gov/35221889